Stock ALGN ALIGN TECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Align Technology, Inc.

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
309 USD -0.48% Intraday chart for Align Technology, Inc. +3.36% +12.78%
Apr. 26 Align Technology to Buy Back $150 Million in Shares MT
Apr. 25 Baird Adjusts Price Target on Align Technology to $370 From $333 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 21,992 42,136 51,821 16,474 20,985 23,255 - -
Enterprise Value (EV) 1 21,123 41,175 50,649 15,474 20,013 21,933 21,730 21,429
P/E ratio 50.5 x 23.8 x 67.8 x 45.7 x 47.2 x 43.3 x 36.4 x 30 x
Yield - - - - - - - -
Capitalization / Revenue 9.14 x 17 x 13.1 x 4.41 x 5.43 x 5.65 x 5.14 x 4.67 x
EV / Revenue 8.78 x 16.7 x 12.8 x 4.14 x 5.18 x 5.33 x 4.81 x 4.3 x
EV / EBITDA 35.6 x 69 x 41.8 x 16.6 x 21 x 21.4 x 18.8 x 16.6 x
EV / FCF 35.3 x 81.2 x 65.7 x 55.9 x 32.9 x 27.9 x 25.1 x 25.6 x
FCF Yield 2.83% 1.23% 1.52% 1.79% 3.04% 3.58% 3.99% 3.9%
Price to Book 16.2 x 13 x 14.3 x 4.52 x 5.78 x 5.8 x 5.22 x 4.44 x
Nbr of stocks (in thousands) 78,813 78,850 78,853 78,112 76,589 75,252 - -
Reference price 2 279.0 534.4 657.2 210.9 274.0 309.0 309.0 309.0
Announcement Date 1/29/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,407 2,472 3,953 3,735 3,862 4,116 4,520 4,983
EBITDA 1 593.5 596.4 1,213 929.6 953.8 1,024 1,154 1,293
EBIT 1 514.5 502.9 1,104 803.8 826 887.1 1,010 1,154
Operating Margin 21.38% 20.34% 27.93% 21.52% 21.39% 21.55% 22.35% 23.17%
Earnings before Tax (EBT) 1 562.7 378.9 1,012 599.1 641.2 731.9 845.1 998.5
Net income 1 442.8 1,776 772 361.6 445.1 541.2 637.7 765
Net margin 18.4% 71.84% 19.53% 9.68% 11.52% 13.15% 14.11% 15.35%
EPS 2 5.530 22.41 9.690 4.610 5.810 7.141 8.481 10.29
Free Cash Flow 1 597.6 507.3 771.4 276.8 608.1 786 867.3 836.4
FCF margin 24.83% 20.52% 19.52% 7.41% 15.74% 19.1% 19.19% 16.79%
FCF Conversion (EBITDA) 100.69% 85.05% 63.61% 29.78% 63.75% 76.79% 75.16% 64.7%
FCF Conversion (Net income) 134.96% 28.56% 99.93% 76.56% 136.63% 145.23% 136% 109.33%
Dividend per Share 2 - - - - - - - -
Announcement Date 1/29/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1,016 1,031 973.2 969.6 890.3 901.5 943.1 1,002 960.2 956.7 997.4 1,041 1,031 1,045 1,073
EBITDA 1 320.5 284 262.7 255.9 212.2 198.8 206.9 245.5 243 258.1 218.4 242.6 267.8 282.3 258.1
EBIT 1 292.9 254.5 233.1 225.6 180 165.1 174.7 213.4 209.7 228 197.5 214.3 229.7 249.4 218.6
Operating Margin 28.83% 24.68% 23.95% 23.27% 20.22% 18.31% 18.52% 21.29% 21.83% 23.83% 19.8% 20.59% 22.28% 23.87% 20.37%
Earnings before Tax (EBT) 1 262 220 187.5 173.6 122.6 115.3 134.6 171.6 162.1 172.9 158.4 172 188.1 208.2 173.4
Net income 1 181 191 134.3 112.8 72.7 41.78 87.8 111.8 121.4 124 105 133.1 142.4 157.6 134.5
Net margin 17.81% 18.52% 13.8% 11.63% 8.17% 4.63% 9.31% 11.16% 12.65% 12.96% 10.53% 12.79% 13.81% 15.08% 12.53%
EPS 2 2.280 2.400 1.700 1.440 0.9300 0.5400 1.140 1.460 1.580 1.640 1.390 1.772 1.913 2.125 1.800
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 10/27/21 2/2/22 4/27/22 7/27/22 10/26/22 2/1/23 4/26/23 7/26/23 10/25/23 1/31/24 4/24/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 869 961 1,171 1,000 973 1,322 1,524 1,826
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 598 507 771 277 608 786 867 836
ROE (net income / shareholders' equity) 34.1% 77.5% 22.5% 10% 18.2% 19.5% 19.8% 20.3%
ROA (Net income/ Total Assets) 19.4% 48.5% 14.3% 6.08% 11% 9.6% 10.3% 10%
Assets 1 2,277 3,665 5,386 5,945 4,062 5,638 6,191 7,650
Book Value Per Share 2 17.20 41.00 46.00 46.60 47.40 53.30 59.20 69.60
Cash Flow per Share 2 9.330 8.360 14.70 7.250 10.30 11.30 13.30 -
Capex 1 150 155 401 292 178 106 207 308
Capex / Sales 6.22% 6.27% 10.15% 7.82% 4.6% 2.59% 4.59% 6.17%
Announcement Date 1/29/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Align Technology, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
309 USD
Average target price
332.2 USD
Spread / Average Target
+7.51%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ALIGN TECHNOLOGY, INC. Stock Align Technology, Inc.
+12.78% 23.25B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ALGN Stock
  4. Financials Align Technology, Inc.